No Data
Hennessy Japan Small Cap Fund Exits Tsubakimoto Chain Co, Impacting Portfolio by -1.78%
December 27 [Today's Investment Strategy]
[Selected Stocks by Fisco] 【Material Stocks】 Kaken Pharmaceutical <4521> 4174 yen (12/26) Main products include the nail fungus treatment 'Klenafin' and the joint function improvement drug 'Alts'. The company announced the signing of a contract granting Johnson & Johnson exclusive rights for the development, manufacturing, and commercialization globally of the 'STAT6 Program', which is being developed as a next-generation oral treatment for type 2 inflammatory diseases (such as atopic dermatitis and asthma).
Focus on DeNA and Kaken Pharmaceutical, while Oisix and Sankyo Tateyama may be sluggish.
In the US stock market on the 26th, the Dow Jones Industrial Average rose by $28.77 to 43,325.80, the Nasdaq Composite Index fell by 10.77 points to 20,020.36, and the Chicago Nikkei 225 Futures were up by 210 yen compared to Osaka daytime at 39,700 yen. The exchange rate was 1 dollar = 158.00-10 yen. In today's Tokyo market, Kusuri no Aoki <3549> saw an increase in operating profit of 85.5%, expanding from 10.2% growth in the first quarter, and the performance of its gaming business for the fiscal year ending in March 2025 is expected to see an increase in both revenue and profit compared to the previous period.
List of Conversion Stocks (Part 1) [List of Parabolic Signal Conversion Stocks]
○ List of stocks transitioning to Buy market Code Stock Name Closing Price SAR Main Board <1518> Mitsui Matsushima HD 3575 3155 <1803> Shimizu Construction 12381177 <1815> Tekken 22852195 <1945> Tokyo Energy System 10571032 <2060> Feed One 778752 <2220> Kameda Confectionery 41503990 <2337> Ichigo 367351 <2379> Dip 244
Three key points to pay attention to in the morning session - Interest is gathering around SOFTBANK GROUP CO.
In the trading session before noon on the 17th, attention should be focused on the following three points. ■ Interest is gathered around SOFTBANK GROUP CO ■ Park24, operating profit in 2024 up 21.0% to 38.6 billion yen, Financial Estimates for 2025 up 0.8% to 39 billion yen ■ Notable materials from the morning session: Mitsui Chemicals <4183> is fostering the medical field, expecting a core operating profit exceeding 10 billion yen by fiscal year 2030. ■ Interest is gathered around SOFTBANK GROUP CO. The Japanese stock market on the 17th is expected to exhibit resilience led by technology stocks.
Mitsui Chemicals, Hitachi, ETC [List of stock materials from the newspaper]
*ENEOS <5020> Group's JX Petroleum Extraction is increasing iodine production in anticipation of demand for perovskite (Nikkankogyo, front page) - ○ *Mitsui Chemicals <4183> is nurturing the medical field, aiming for core operating profit of over 10 billion yen by fiscal year 2030 (Nikkankogyo, front page) - ○ *Hitachi <6501> appoints Tokunaga as president, expanding digital and social infrastructure (Nikkankogyo, front page) - ○ *Hitachi <6501> new management structure focuses on solving social issues, introducing AI, and competing globally (Nikkankogyo, page 3) - ○ *Sumitomo Corporation <8053> industrial group in India.